Global Orthopedic Hyaluronic Acid Care Market is valued USD 3.93 Billion in 2019 and is projected is to exhibit 8.3% CAGR during the forecast period. The market is projected to be around USD 6.87 Billion by 2026. The market is driven by the increasing prevalence of the patient pool suffering from knee osteoarthritis.

Osteoarthritis is one of the serious weakening diseases that has increased in number across the world due to the aging population. It is degenerative joint disease that frequently affects the hands and weight-bearing joints of the body. Despite advancements in medical science and with a variety of alternative treatments available, osteoarthritis still remains incurable today, though the pain can be minimized substantially. The main reason for the bone pain is due to lack of hyaluronate which is a natural substance produced by every joint by our body. Hyaluronic acid (HA) is one of the recent techniques which have proved beneficial in reducing the pain related to osteoarthritis either through an injectable or oral supplement for treatment.
Orthopedic Hyaluronic Acid Care Market Dynamics
The global orthopedic hyaluronic acid market is growing due to factors such as the increasing prevalence of the patient pool suffering from knee osteoarthritis, the rising popularity of minimally invasive procedures, and the increasing geriatric population. Knee osteoarthritis is a common disease and is one of the leading causes of disability among the geriatric population. With the increase in the age of the general population, there is a growing prevalence of knee osteoarthritis. However, the lack of eagerness of the surgeons and the reimbursement challenges also limit the growth of the orthopedic hyaluronic acid market.
Orthopedic Hyaluronic Acid Care Market Insight
Based on the region North America accounted for the highest market share in the orthopedic hyaluronic acid market. Due to the presence of a sizeable base of geriatric population, this is more susceptive to disorders such as osteoarthritis, vesicoureteral reflux, and cataracts. Furthermore, the increasing demand for minimally invasive cosmetic surgeries is a significant factor contributing to the large share of North America.
Orthopedic Hyaluronic Acid Care Market Segmentation
The global Orthopedic Hyaluronic Acid Care market is segmented into Type, Application, and region. On the basis of the Type the market is further bifurcated into single injection, three injections, and five injections. The market based on Application is segmented into hospitals, ambulatory surgical centres, and orthopedic clinics. Based on the region the market is further segregated into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
Orthopedic Hyaluronic Acid Care Market Competitive Landscape
The key players in Orthopedic Hyaluronic Acid Care Market are listed as Anika Therapeutics, Inc., Sanofi, Zimmer Biomet Holdings, Inc, Ferring Pharmaceuticals Inc, Fidia Farmaceutici S.p.A, Bioventus LLC among others.